Literature DB >> 10968896

Antiphospholipid antibodies, malignancies and paraproteinemias.

R A Asherson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10968896     DOI： 10.1006/jaut.2000.0404

Source DB:  PubMed          Journal:  J Autoimmun        ISSN： 0896-8411            Impact factor:   7.094


× No keyword cloud information.
  10 in total

1.  High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma.

Authors:  W Miesbach; I Scharrer; R A Asherson
Journal:  Clin Rheumatol       Date:  2006-05-24       Impact factor: 2.980

2.  Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies.

Authors:  Wolfgang Miesbach; Inge Scharrer; Ronald Asherson
Journal:  Clin Rheumatol       Date:  2006-01-25       Impact factor: 2.980

3.  Alveolar and serum antiphospholipid antibodies in acute respiratory distress syndrome associated with catastrophic antiphospholipid syndrome.

Authors:  F J Wiedermann
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

4.  Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study.

Authors:  Mario Bazzan; Barbara Montaruli; Antonella Vaccarino; Gianni Fornari; Maddalena Saitta; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2009-09-26       Impact factor: 3.397

Review 5.  Malignancies and catastrophic anti-phospholipid syndrome.

Authors:  Wolfgang Miesbach
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 6.  Antiphospholipid syndrome and cancer.

Authors:  Eyal Reinstein; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

7.  The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.

Authors:  W Miesbach; R A Asherson; R Cervera; Y Shoenfeld; J Gomez Puerta; G Espinosa; S Bucciarelli
Journal:  Clin Rheumatol       Date:  2007-05-24       Impact factor: 2.980

8.  Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis.

Authors:  Iván Palomo; Jaime Pereira; Marcelo Alarcón; Marcela Vásquez; Carmen Pinochet; María T Vélez; Jorge Sandoval; Gloria Icaza; Silvia Pierangeli
Journal:  Clin Rheumatol       Date:  2004-01-31       Impact factor: 2.980

9.  Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

Authors:  Khaldoun Alkayed; Kandice Kottke-Marchant
Journal:  Korean J Hematol       Date:  2011-12-27

10.  Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort.

Authors:  Jean-Christophe Gris; Éve Mousty; Sylvie Bouvier; Sylvie Ripart; Éva Cochery-Nouvellon; Pascale Fabbro-Peray; Jonathan Broner; Vincent Letouzey; Antonia Pérez-Martin
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.